Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

KURA holding history

Kura Oncology, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KURA overviewAll 13F holders of KURAFull Q2 2026 holdings

Shares (Q2 2026)
14,062
Value
$154.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of KURA by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,062$154.3K<0.1%−1,520−9.8%ReducedHolders
Q1 202615,582$126.7K<0.1%−2,990−16.1%ReducedHolders
Q4 202518,572$193.0K<0.1%+1,692+10.0%AddedHolders
Q3 202516,880$149.4K<0.1%−2,569−13.2%ReducedHolders
Q2 202519,449$112.2K<0.1%−216−1.1%ReducedHolders
Q1 202519,665$129.8K<0.1%−4,438−18.4%ReducedHolders
Q4 202424,103$209.9K<0.1%+5,873+32.2%AddedHolders
Q3 202418,230$356.2K<0.1%+4,075+28.8%AddedHolders
Q2 202414,155$291.5K<0.1%−3,859−21.4%ReducedHolders
Q1 202418,014$384.2K<0.1%+1,588+9.7%AddedHolders
Q4 202316,426$236.2K<0.1%+2,407+17.2%AddedHolders
Q3 202314,019$127.9K<0.1%+1,114+8.6%AddedHolders
Q2 202312,905$136.5K<0.1%+510+4.1%AddedHolders
Q1 202312,395$151.6K<0.1%−1,614−11.5%ReducedHolders
Q4 202214,009$173.9K<0.1%+1,388+11.0%AddedHolders
Q3 202212,621$173.0K<0.1%+303+2.5%AddedHolders
Q2 202212,318$226.0K<0.1%−6,491−34.5%ReducedHolders
Q1 202218,809$302.0K<0.1%−4,423−19.0%ReducedHolders
Q4 202123,232$325.0K<0.1%+928+4.2%AddedHolders
Q3 202122,304$418.0K<0.1%−6,089−21.4%ReducedHolders
Q2 202128,393$592.0K<0.1%+2,510+9.7%AddedHolders
Q1 202125,883$732.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.